MacroGenics, Inc. Gains 230.92%
Wed, May 06, 2020 at 05:30 PM
MacroGenics, Inc. (MGNX:NASDAQ) rocketted at $25.15, a gain of 230.9%. On Tue 05 May 20, MGNX:NASDAQ hit a New 2-Week High of $7.6. The stock appeared on our News Catalysts scanner on Wed 29 Apr 20 at 06:11 AM in the 'MISCELLANEOUS' category. From Tue 21 Apr 20, the stock recorded 60.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About MacroGenics, Inc. (MGNX:NASDAQ)
Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.
Top 10 Gainers:
- MacroGenics, Inc. (MGNX:NASDAQ), 230.92%
- China Rapid Finance Limited (XRF:NYSE), 75.53%
- Remark Holdings, Inc. (MARK:NASDAQ), 65.16%
- IZEA Worldwide, Inc. (IZEA:NASDAQ), 53.39%
- Cars.com Inc. (CARS:NYSE), 52.88%
- Genius Brands International, Inc. (GNUS:NASDAQ), 49.07%
- LivePerson, Inc. (LPSN:NASDAQ), 40.32%
- Vapotherm, Inc. (VAPO:NYSE), 34.53%
- AutoWeb, Inc. (AUTO:NASDAQ), 34.53%
- Inuvo, Inc. (INUV:NYSEMKT), 33.38%